Thus, even a modest decrease in RhoA activation in association with rictor gene-silencing may be significant in the bladder cancer cells.
← all excerpts
Mammalian target of rapamycin complex 2 (mTORC2) is a critical determinant of bladder cancer invasion.
1
—
—